• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DEGRO 中枢神经系统放射性坏死实践指南第 1 部分:分类和多步骤诊断方法。

DEGRO practical guideline for central nervous system radiation necrosis part 1: classification and a multistep approach for diagnosis.

机构信息

Klinik und Poliklinik für Radioonkologie und Strahlentherapie, Klinikum rechts der Isar, Technische Universität München, Ismaninger Str. 22, 81675, München, Germany.

Partner Sites Munich, Freiburg and Heidelberg, Deutsches Konsortium für Translationale Krebsforschung (DKTK), Heidelberg, Germany.

出版信息

Strahlenther Onkol. 2022 Oct;198(10):873-883. doi: 10.1007/s00066-022-01994-3. Epub 2022 Aug 29.

DOI:10.1007/s00066-022-01994-3
PMID:36038669
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9515024/
Abstract

PURPOSE

The Working Group for Neuro-Oncology of the German Society for Radiation Oncology in cooperation with members of the Neuro-Oncology Working Group of the German Cancer Society aimed to define a practical guideline for the diagnosis and treatment of radiation-induced necrosis (RN) of the central nervous system (CNS).

METHODS

Panel members of the DEGRO working group invited experts, participated in a series of conferences, supplemented their clinical experience, performed a literature review, and formulated recommendations for medical treatment of RN including bevacizumab in clinical routine.

CONCLUSION

Diagnosis and treatment of RN requires multidisciplinary structures of care and defined processes. Diagnosis has to be made on an interdisciplinary level with the joint knowledge of a neuroradiologist, radiation oncologist, neurosurgeon, neuropathologist, and neuro-oncologist. A multistep approach as an opportunity to review as many characteristics as possible to improve diagnostic confidence is recommended. Additional information about radiotherapy (RT) techniques is crucial for the diagnosis of RN. Misdiagnosis of untreated and progressive RN can lead to severe neurological deficits. In this practice guideline, we propose a detailed nomenclature of treatment-related changes and a multistep approach for their diagnosis.

摘要

目的

德国放射肿瘤学会神经肿瘤学工作组与德国癌症学会神经肿瘤学工作组的成员合作,旨在为中枢神经系统(CNS)放射性坏死(RN)的诊断和治疗制定实用指南。

方法

DEGRO 工作组的小组成员邀请专家参加了一系列会议,补充了他们的临床经验,对文献进行了回顾,并制定了包括贝伐单抗在内的 RN 医学治疗建议,纳入临床常规。

结论

RN 的诊断和治疗需要多学科的护理结构和明确的流程。诊断需要在多学科层面上进行,由神经放射科医生、放射肿瘤学家、神经外科医生、神经病理学家和神经肿瘤科医生共同参与。建议采用多步骤的方法,有机会尽可能多地回顾各种特征,以提高诊断信心。关于放射治疗(RT)技术的更多信息对于 RN 的诊断至关重要。对未治疗和进展性 RN 的误诊可导致严重的神经功能缺损。在本实践指南中,我们提出了一个详细的治疗相关变化命名法,并提出了一个多步骤的诊断方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca95/9515024/3bf20f62ec2f/66_2022_1994_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca95/9515024/3bf20f62ec2f/66_2022_1994_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca95/9515024/3bf20f62ec2f/66_2022_1994_Fig1_HTML.jpg

相似文献

1
DEGRO practical guideline for central nervous system radiation necrosis part 1: classification and a multistep approach for diagnosis.DEGRO 中枢神经系统放射性坏死实践指南第 1 部分:分类和多步骤诊断方法。
Strahlenther Onkol. 2022 Oct;198(10):873-883. doi: 10.1007/s00066-022-01994-3. Epub 2022 Aug 29.
2
DEGRO practical guideline for central nervous system radiation necrosis part 2: treatment.DEGRO 中枢神经系统放射性坏死实践指南第 2 部分:治疗。
Strahlenther Onkol. 2022 Nov;198(11):971-980. doi: 10.1007/s00066-022-01973-8. Epub 2022 Aug 29.
3
Bevacizumab for radiation necrosis following radiotherapy of brain metastatic disease: a systematic review & meta-analysis.贝伐单抗治疗脑转移瘤放疗后放射性坏死:系统评价与荟萃分析。
BMC Cancer. 2021 Feb 16;21(1):167. doi: 10.1186/s12885-021-07889-3.
4
Moderately hypofractionated radiotherapy as definitive treatment for localized prostate cancer: Pattern of practice in German-speaking countries : A survey of the Prostate Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO) and the Working Party on Radiation Oncology of the German Cancer Society (DKG-ARO).中低分割放射治疗作为局限性前列腺癌的确定性治疗:德语国家的实践模式:德国放射肿瘤学会前列腺癌专家小组(DEGRO)和德国癌症学会放射肿瘤学工作组(DKG-ARO)的调查。
Strahlenther Onkol. 2021 Nov;197(11):993-1000. doi: 10.1007/s00066-021-01820-2. Epub 2021 Aug 31.
5
Targeted intraarterial anti-VEGF therapy for medically refractory radiation necrosis in the brain.靶向动脉内抗血管内皮生长因子治疗脑内难治性放射性坏死
J Neurosurg Pediatr. 2015 Jan;15(1):20-5. doi: 10.3171/2014.9.PEDS14198.
6
The development of quality assurance programs for radiotherapy within the German Hodgkin Study Group (GHSG). Introduction, continuing work, and results of the radiotherapy reference panel.德国霍奇金淋巴瘤研究组(GHSG)内放射治疗质量保证计划的发展。放疗参考小组的介绍、持续工作及成果。
Strahlenther Onkol. 2005 Sep;181(9):557-66. doi: 10.1007/s00066-005-1437-0.
7
Treatment of cerebral radiation necrosis with bevacizumab: the Cleveland clinic experience.贝伐单抗治疗脑放射性坏死:克利夫兰诊所的经验
Am J Clin Oncol. 2015 Jun;38(3):304-10. doi: 10.1097/COC.0b013e31829c3139.
8
Mortality of early treatment for radiation-induced brain necrosis in head and neck cancer survivors: A multicentre, retrospective, registry-based cohort study.头颈部癌幸存者放射性脑坏死早期治疗的死亡率:一项基于多中心、回顾性登记的队列研究。
EClinicalMedicine. 2022 Aug 12;52:101618. doi: 10.1016/j.eclinm.2022.101618. eCollection 2022 Oct.
9
Results of a questionnaire regarding practice patterns for the diagnosis and treatment of intracranial radiation necrosis after SRS.SRS 后颅内放射性坏死的诊断和治疗实践模式问卷调查结果。
J Neurooncol. 2013 Dec;115(3):469-75. doi: 10.1007/s11060-013-1248-6. Epub 2013 Sep 18.
10
Bevacizumab as a treatment for radiation necrosis following stereotactic radiosurgery for brain metastases: clinical and radiation dosimetric impacts.贝伐单抗治疗脑转移瘤立体定向放射外科术后放射性坏死:临床及放射剂量学影响
Ann Palliat Med. 2021 Feb;10(2):2018-2026. doi: 10.21037/apm-20-2417. Epub 2021 Feb 3.

引用本文的文献

1
Immune Checkpoint Inhibition in Patients with Brain Metastases from Non-Small-Cell Lung Cancer: Emerging Mechanisms and Personalized Clinical Strategies.非小细胞肺癌脑转移患者的免疫检查点抑制:新出现的机制和个性化临床策略
Int J Mol Sci. 2025 Sep 4;26(17):8624. doi: 10.3390/ijms26178624.
2
Radiation-induced changes of reactive astrocyte distribution in mice as a late response to partial-brain proton irradiation.作为对部分脑质子照射的晚期反应,辐射诱导小鼠反应性星形胶质细胞分布的变化。
Acta Oncol. 2025 Jul 23;64:902-908. doi: 10.2340/1651-226X.2025.44056.
3
Effects of concurrent HER2-directed therapy on development of cerebral radionecrosis after stereotactic radiotherapy: a systematic review.

本文引用的文献

1
Radiation induced contrast enhancement after proton beam therapy in patients with low grade glioma - How safe are protons?质子束治疗低级别胶质瘤后引起的辐射对比增强 - 质子治疗安全吗?
Radiother Oncol. 2022 Feb;167:211-218. doi: 10.1016/j.radonc.2021.12.035. Epub 2021 Dec 29.
2
A multi-center prospective study of re-irradiation with bevacizumab and temozolomide in patients with bevacizumab refractory recurrent high-grade gliomas.贝伐珠单抗联合替莫唑胺挽救性再放疗治疗贝伐珠单抗耐药复发性高级别胶质瘤的多中心前瞻性研究。
J Neurooncol. 2021 Dec;155(3):297-306. doi: 10.1007/s11060-021-03875-8. Epub 2021 Oct 24.
3
Fully automated analysis combining [F]-FET-PET and multiparametric MRI including DSC perfusion and APTw imaging: a promising tool for objective evaluation of glioma progression.
人表皮生长因子受体2(HER2)靶向联合治疗对立体定向放射治疗后脑放射性坏死发生的影响:一项系统评价
Strahlenther Onkol. 2025 Jun 10. doi: 10.1007/s00066-025-02416-w.
4
Stereotactic radiosurgery for patients with brain metastases: current principles, expanding indications and opportunities for multidisciplinary care.脑转移瘤患者的立体定向放射外科治疗:当前原则、适应证扩展及多学科治疗机遇
Nat Rev Clin Oncol. 2025 May;22(5):327-347. doi: 10.1038/s41571-025-01013-1. Epub 2025 Mar 19.
5
Aberrant choroid plexus formation drives the development of treatment-related brain toxicity.异常脉络丛形成驱动与治疗相关的脑毒性发展。
Commun Biol. 2025 Feb 22;8(1):276. doi: 10.1038/s42003-025-07736-2.
6
Fractionated stereotactic radiotherapy of brainstem metastases - Clinical outcome and prognostic factors.脑干转移瘤的分次立体定向放射治疗——临床结果及预后因素
Clin Transl Radiat Oncol. 2024 Nov 21;50:100893. doi: 10.1016/j.ctro.2024.100893. eCollection 2025 Jan.
7
Radiotherapy in patients with brain metastases with and without concomitant immunotherapy: comparison of patient outcome and neurotoxicity.伴有或不伴有同步免疫治疗的脑转移患者的放射治疗:患者预后和神经毒性的比较
Discov Oncol. 2024 Nov 15;15(1):656. doi: 10.1007/s12672-024-01560-6.
8
Effect of different optimization parameters in single isocenter multiple brain metastases radiosurgery.单中心多脑转移瘤放射外科中不同优化参数的影响。
Strahlenther Onkol. 2024 Sep;200(9):815-826. doi: 10.1007/s00066-024-02249-z. Epub 2024 Jul 8.
9
Resolving spatial response heterogeneity in glioblastoma.解决胶质母细胞瘤的空间反应异质性。
Eur J Nucl Med Mol Imaging. 2024 Oct;51(12):3685-3695. doi: 10.1007/s00259-024-06782-y. Epub 2024 Jun 5.
10
Fractionated stereotactic radiotherapy of intracranial postoperative cavities after resection of brain metastases - Clinical outcome and prognostic factors.脑转移瘤切除术后颅内术腔的分次立体定向放射治疗——临床结果及预后因素
Clin Transl Radiat Oncol. 2024 Apr 21;46:100782. doi: 10.1016/j.ctro.2024.100782. eCollection 2024 May.
结合 [F]-FET-PET 和多参数 MRI(包括 DSC 灌注和 APTw 成像)的全自动分析:一种用于客观评估胶质瘤进展的有前途的工具。
Eur J Nucl Med Mol Imaging. 2021 Dec;48(13):4445-4455. doi: 10.1007/s00259-021-05427-8. Epub 2021 Jun 25.
4
How can scanned proton beam treatment planning for low-grade glioma cope with increased distal RBE and locally increased radiosensitivity for late MR-detected brain lesions?对于低级别胶质瘤的扫描质子束治疗计划,如何应对晚期磁共振检测到的脑病变中增加的远隔相对生物效应(RBE)和局部增加的放射敏感性?
Med Phys. 2021 Apr;48(4):1497-1507. doi: 10.1002/mp.14739. Epub 2021 Feb 22.
5
Immune checkpoint inhibitor therapy may increase the incidence of treatment-related necrosis after stereotactic radiosurgery for brain metastases: a systematic review and meta-analysis.免疫检查点抑制剂治疗可能会增加立体定向放射外科治疗脑转移瘤后治疗相关性坏死的发生率:系统评价和荟萃分析。
Eur Radiol. 2021 Jun;31(6):4114-4129. doi: 10.1007/s00330-020-07514-0. Epub 2020 Nov 25.
6
Sequential implementation of DSC-MR perfusion and dynamic [F]FET PET allows efficient differentiation of glioma progression from treatment-related changes.序贯实施 DSC-MR 灌注和动态 [F]FET PET 可有效区分胶质瘤进展与治疗相关变化。
Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):1956-1965. doi: 10.1007/s00259-020-05114-0. Epub 2020 Nov 26.
7
Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.中枢神经系统癌症,第 3.2020 版,NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2020 Nov 2;18(11):1537-1570. doi: 10.6004/jnccn.2020.0052.
8
Dose dependent cerebellar atrophy in glioma patients after radio(chemo)therapy.放化疗后胶质瘤患者小脑剂量依赖性萎缩。
Radiother Oncol. 2020 Sep;150:262-267. doi: 10.1016/j.radonc.2020.07.044. Epub 2020 Jul 31.
9
Temporal Lobe Necrosis in Head and Neck Cancer Patients after Proton Therapy to the Skull Base.头颈部癌患者在质子治疗颅底后出现的颞叶坏死
Int J Part Ther. 2020 Spring;6(4):17-28. doi: 10.14338/IJPT-20-00014.1. Epub 2020 May 28.
10
Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases: The FIRE-SCLC Cohort Study.小细胞肺癌脑转移一线立体定向放疗与全脑放疗的评价:FIRE-SCLC 队列研究。
JAMA Oncol. 2020 Jul 1;6(7):1028-1037. doi: 10.1001/jamaoncol.2020.1271.